Alzheimer’s is actually a detectable disease. Doctors resort to systems that can scan the brain, such as magnetic resonance imaging (MRI), positron emitting tomography (PET), and EEG to diagnose this disease definitively. A new one is about to be added to these methods.New blood test tested on 600 patients
Researchers from Sweden, Italy, the UK and the USA talked about the corresponding blood test, which is antibody-based. This test can detect brain-derived tau proteins that are specific to Alzheimer’s disease.
Tau protein plays an important role in the regulation of microtubules that make up the cytoskeleton. It was learned that this blood test, which was tested on patients, was able to distinguish Alzheimer’s and other neurologic diseases with a high accuracy rate.
Working as a professor of psychiatry at the University of Pittsburgh and making various contributions to the development of this blood test, Dr. Thomas Karikari hopes this invention will help other studies for the treatment of Alzheimer’s disease.Because a blood test is much cheaper and more reliable. It’s also relatively easy to get blood. Karikari said that this test may not be widespread in hospitals yet and has not been tested enough. There is still a lot of work to be done in the medical sense, according to him. 600 patients is not enough.
25360
